The impact of skin disease following renal transplantation on quality of life

British Journal of Dermatology

Volumn 153, Issue 3, 2005, Pages 574-578

  Moloney, Fergal J ^a   Keane, S ^a   O'Kelly, P ^a   Conlon, P J ^a   Murphy, G M ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Acne; Genital warts; Hypertrichosis; Pruritus; Recurrent HSV infections; Sebaceous gland hyperplasia

Indexed keywords

ACNE; ADULT; AGE; ARTICLE; CONDYLOMA; DISEASE ASSOCIATION; DRY SKIN; FEMALE; GENDER; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HYPERTRICHOSIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRE; SKIN DISEASE; SKIN INFECTION;

ADULT; AGE FACTORS; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; SEX FACTORS; SKIN DISEASES; SKIN NEOPLASMS; TIME FACTORS;

EID: 24344448318     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06699.x     Document Type: Article

References (19)

1. Moloney FJ, de Freitas D, Conlon PJ, Murphy GM. Renal transplantation, immunosuppression and the skin: an update. Photodermatol Photoimmunol Photomed 2005;21:1-6.
2. Leigh IM, Glover MT. Skin cancer and warts in immunosuppressed renal transplant recipients. Rec Results Canc Res 1995; 139:69-86.
3. Carroll RP, Ramsay HM, Fryer AA et al. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland. Australia Am J Kidney Dis 2003; 41:676-83.
4. Keown P. Improving quality of life - the new target for transplantation. Transplantation 2001; 72:S67-74.
5. Evans RW, Manninen DL, Garrison LP Jr et al. The quality of life of patients with end-stage renal disease. N Engl J Med 1985; 312:553-9.
6. Mallon E, Newton JN, Klassen A et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999; 140:672-6.
7. Williamson D, Gonzalez M, Finlay AY. The effect of hair loss on quality of life. J Eur Acad Dermatol Venereol 2000; 15:137-9.
8. Fiebiger W, Mitterbauer C, Oberhauer R. Health-related quality of life outcomes after kidney transplantation. Health Qual Life Outcomes 2004; 2:2. http://www.hqlo.com/content/2/1/2 Accessed 5 March 2005.
9. Rhee JS, Matthews BA, Neuburg M et al. Skin cancer and quality of life: assessment with the Dermatology Life Quality Index. Dermatol Surg 2004; 30:525-9.
10. Sonino N, Fava GA, Mani E et al. Quality of life of hirsute women. Postgrad Med J 1993; 69:186-9.
11. Didlake RH, Dreyfus K, Kerman RH et al. Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc 1988; 20:63-9.
12. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19:210-16.
13. World Health Organization. The First Ten Years of the World Health Organization. Geneva: World Health Organization, 1958.
14. Jayaprakasam A, Darvay A, Osborne G, McGibbon D. Comparison of assessments of severity and quality of life in cutaneous disease. Clin Exp Dermatol 2002; 27:306-8.
15. Laupacis A, Keown P, Pus N et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50:235-42.
16. Morgan M, McCreedy R, Simpson J, Hay RJ. Dermatology quality of life scales - a measure of the impact of skin diseases. Br J Dermatol 1997; 136:202-6.
17. Slevin ML, Plant H. Who should measure quality of life, the doctor or the patient? Br J Cancer 1988; 57:109-12.
18. Shield CF III, McGrath MM, Goss TF. Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression. Fk506 Kidney Transplant Study Group Transplantation 1997; 64:1738-43.
19. Artz MA, Boots JM, Ligtenberg G et al. Conversion from cyclosporin to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. Am J Transplant 2004; 4:937-45.